BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26753394)

  • 1. [Technical Approaches for Quantitative Treatment Responses Using 18F-FDG PET].
    Miwa K; Miyaji N; Umeda T; Murata T; Wagatsuma K; Sasaki M
    Igaku Butsuri; 2015; 35(1):30-8. PubMed ID: 26753394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Bailey DL
    J Nucl Med; 2010 Jan; 51(1):165-6; author reply 166-7. PubMed ID: 20008991
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S; Rao R
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract]   [Full Text] [Related]  

  • 4. Standards for PET image acquisition and quantitative data analysis.
    Boellaard R
    J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
    Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
    J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncology PET imaging].
    Inubushi M
    Igaku Butsuri; 2014; 34(1):3-9. PubMed ID: 25199271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of Determining Acquisition Time by True Count Rate Measurement Method for Delivery 18F-FDG PET/CT].
    Miura S; Odashima S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Mar; 72(3):218-26. PubMed ID: 27000670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring response to therapeutic interventions in patients with cancer.
    Herrmann K; Krause BJ; Bundschuh RA; Dechow T; Schwaiger M
    Semin Nucl Med; 2009 May; 39(3):210-32. PubMed ID: 19341841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quality control of PET imaging: from study to diagnosis].
    Daisaki H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2012; 68(7):916-25. PubMed ID: 22821167
    [No Abstract]   [Full Text] [Related]  

  • 10. Parametric imaging: a promising approach for the evaluation of dynamic PET-18F-FDG studies - the DKFZ experience.
    Dimitrakopoulou-Strauss A; Pan L; Strauss LG
    Hell J Nucl Med; 2010; 13(1):18-22. PubMed ID: 20411165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of the PET for Radiation Therapy].
    Mitsumoto T; Tohyama N; Koyama K; Kodama T; Kotaka K; Hatano K
    Igaku Butsuri; 2015; 35(1):39-44. PubMed ID: 26753395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG PET/CT in oncology: "raising the bar".
    Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
    Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology.
    Larson SM; Schwartz LH
    J Nucl Med; 2006 Jun; 47(6):901-3. PubMed ID: 16741296
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on PET radiopharmaceuticals: life beyond fluorodeoxyglucose.
    Shiue CY; Welch MJ
    Radiol Clin North Am; 2004 Nov; 42(6):1033-53, viii. PubMed ID: 15488556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
    Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
    Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET-CT in oncology.
    Purandare NC; Rangarajan V
    J Postgrad Med; 2010; 56(2):103-8. PubMed ID: 20622389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary.
    Freudenberg LS; Fischer M; Antoch G; Jentzen W; Gutzeit A; Rosenbaum SJ; Bockisch A; Egelhof T
    Med Princ Pract; 2005; 14(3):155-60. PubMed ID: 15863988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The PET, Past and Future].
    Fujii H
    Igaku Butsuri; 2015; 35(1):2-9. PubMed ID: 26753390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferation imaging with ¹⁸F-fluorothymidine PET/computed tomography: physiologic uptake, variants, and pitfalls.
    Herrmann K; Buck AK
    PET Clin; 2014 Jul; 9(3):331-8. PubMed ID: 25030396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.